Faiz Anwer

68PUBLICATIONS
205CO-AUTHORS
Ngā kōhanga reo (Māori curriculum and pedagogy)Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Medical biotechnology diagnostics (incl. biosensors)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (68)

|Jun 03, 2026
Multiple Myeloma Screening Education: A Community-Based Health Literacy Intervention.

|Apr 23, 2026
Functional high-risk phenotype predicts poor survival in multiple myeloma independent of front-line treatment: A secondary analysis of CIBMTR data.

|Mar 28, 2026
Real-world outcomes with elranatamab in multiple myeloma: a multicenter analysis from the U.S. Multiple Myeloma Immunotherapy Consortium.

Andrew J Portuguese, James A Davis, Shahzad Raza

|Jan 12, 2026
Multiple Myeloma Management in a Large Low- and Middle-Income Country: Lessons From India in Balancing Cost and Clinical Efficacy in Resource-Limited Settings.

Prabhat Gautam Roy, Ajay Gogia, Zain Anwar

|Nov 28, 2025
The impact of extramedullary and paraskeletal plasmacytomas on treatment outcomes in multiple myeloma treated with teclistamab: U.S. Myeloma Immunotherapy Consortium real-world experience.

Aimaz Afrough, Danai Dima, Beatrice Razzo

|Sep 22, 2025
Molecular Expression Differences in Specific Blood Mononuclear Cell-Types Identify Patients With AL Amyloidosis.

David Kaplan, Eric Christian, Jason Valent

Pageof 12

Frequent Collaborators

22 joint publications

Jack Khouri

20 joint publications

Shahzad Raza

14 joint publications

James A Davis

13 joint publications

Danai Dima